Hemodynamic Effects of Cyclic Guanosine Monophosphate-Dependent Signaling Through β3 Adrenoceptor Stimulation in Patients With Advanced Heart Failure: A Randomized Invasive Clinical Trial.

MLA

Bundgaard, Henning, et al. “Hemodynamic Effects of Cyclic Guanosine Monophosphate-Dependent Signaling Through Β3 Adrenoceptor Stimulation in Patients With Advanced Heart Failure: A Randomized Invasive Clinical Trial.” Circulation. Heart Failure, vol. 15, no. 7, July 2022, p. e009120. EBSCOhost, https://doi.org/10.1161/CIRCHEARTFAILURE.121.009120.

APA

Bundgaard, H., Axelsson Raja, A., Iversen, K., Valeur, N., Tønder, N., Schou, M., Christensen, A. H., Bruun, N. E., Søholm, H., Ghanizada, M., Fry, N. A. S., Hamilton, E. J., Boesgaard, S., Møller, M. B., Wolsk, E., Rossing, K., Køber, L., Rasmussen, H. H., & Vissing, C. R. (2022). Hemodynamic Effects of Cyclic Guanosine Monophosphate-Dependent Signaling Through β3 Adrenoceptor Stimulation in Patients With Advanced Heart Failure: A Randomized Invasive Clinical Trial. Circulation. Heart Failure, 15(7), e009120. https://doi.org/10.1161/CIRCHEARTFAILURE.121.009120

Chicago

Bundgaard, Henning, Anna Axelsson Raja, Kasper Iversen, Nana Valeur, Niels Tønder, Morten Schou, Alex Hørby Christensen, et al. 2022. “Hemodynamic Effects of Cyclic Guanosine Monophosphate-Dependent Signaling Through Β3 Adrenoceptor Stimulation in Patients With Advanced Heart Failure: A Randomized Invasive Clinical Trial.” Circulation. Heart Failure 15 (7): e009120. doi:10.1161/CIRCHEARTFAILURE.121.009120.